Literature DB >> 33482061

Chemical Diversification of Simple Synthetic Antibodies.

Mariha Islam1, Haixing P Kehoe1, Jacob B Lissoos1, Manjie Huang1, Christopher E Ghadban1, Greg Berumen Sánchez1, Hanan Z Lane1, James A Van Deventer1,2.   

Abstract

Antibodies possess properties that make them valuable as therapeutics, diagnostics, and basic research tools. However, antibody chemical reactivity and covalent antigen binding are constrained, or even prevented, by the narrow range of chemistries encoded in canonical amino acids. In this work, we investigate strategies for leveraging an expanded range of chemical functionality using yeast displayed antibodies containing noncanonical amino acids (ncAAs) in or near antibody complementarity determining regions (CDRs). To enable systematic characterization of the effects of ncAA incorporation on antibody function, we first investigated whether diversification of a single antibody loop would support the isolation of binding clones against immunoglobulins from three species. We constructed and screened a billion-member library containing canonical amino acid diversity and loop length diversity only within the third complementarity determining region of the heavy chain (CDR-H3). Isolated clones exhibited moderate affinities (double- to triple-digit nanomolar affinities) and, in several cases, single-species specificity, confirming that antibody specificity can be mediated by a single CDR. This constrained diversity enabled the utilization of additional CDRs for the installation of chemically reactive and photo-cross-linkable ncAAs. Binding studies of ncAA-substituted antibodies revealed that ncAA incorporation is reasonably well tolerated, with observed changes in affinity occurring as a function of ncAA side chain identity, substitution site, and the ncAA incorporation machinery used. Multiple azide-containing ncAAs supported copper-catalyzed azide-alkyne cycloaddition (CuAAC) and strain-promoted azide-alkyne cycloaddition (SPAAC) without the abrogation of binding function. Similarly, several alkyne substitutions facilitated CuAAC without the apparent disruption of binding. Finally, antibodies substituted with a photo-cross-linkable ncAA were evaluated for ultraviolet-mediated cross-linking on the yeast surface. Competition-based assays revealed position-dependent covalent linkages, strongly suggesting successful cross-linking. Key findings regarding CuAAC reactions and photo-cross-linking on the yeast surface were confirmed using soluble forms of ncAA-substituted clones. The consistency of findings on the yeast surface and in solution suggest that chemical diversification can be incorporated into yeast display screening approaches. Taken together, our results highlight the power of integrating the use of yeast display and ncAAs in search of proteins with "chemically augmented" binding functions. This includes strategies for systematically introducing small molecule functionality within binding protein structures and evaluating protein-based covalent target binding. The efficient preparation and chemical diversification of antibodies on the yeast surface open up new possibilities for discovering "drug-like" protein leads in high throughput.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33482061      PMCID: PMC8096149          DOI: 10.1021/acschembio.0c00865

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  87 in total

1.  Selection of optical biosensors from chemisynthetic antibody libraries.

Authors:  Laurent Jespers; Timothy P Bonnert; Greg Winter
Journal:  Protein Eng Des Sel       Date:  2004-11-10       Impact factor: 1.650

2.  Phage Selection of Cyclic Peptides for Application in Research and Drug Development.

Authors:  Kaycie Deyle; Xu-Dong Kong; Christian Heinis
Journal:  Acc Chem Res       Date:  2017-07-18       Impact factor: 22.384

3.  High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.

Authors:  Frederic A Fellouse; Kaori Esaki; Sara Birtalan; Demetrios Raptis; Vincenzo J Cancasci; Akiko Koide; Parkash Jhurani; Mark Vasser; Christian Wiesmann; Anthony A Kossiakoff; Shohei Koide; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2007-08-19       Impact factor: 5.469

4.  Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.

Authors:  E A Kabat; T T Wu
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

5.  Genetically Encoded Fragment-Based Discovery from Phage-Displayed Macrocyclic Libraries with Genetically Encoded Unnatural Pharmacophores.

Authors:  Arunika I Ekanayake; Lena Sobze; Payam Kelich; Jihea Youk; Nicholas J Bennett; Raja Mukherjee; Atul Bhardwaj; Frank Wuest; Lela Vukovic; Ratmir Derda
Journal:  J Am Chem Soc       Date:  2021-03-30       Impact factor: 15.419

6.  Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

Authors:  Ryan L Kelly; Doris Le; Jessie Zhao; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-11-26       Impact factor: 5.469

7.  Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential.

Authors:  Ciara M Mahon; Matthew A Lambert; Jacob Glanville; Jason M Wade; Brian J Fennell; Mark R Krebs; Douglas Armellino; Sharon Yang; Xuemei Liu; Cliona M O'Sullivan; Benedicte Autin; Katarzyna Oficjalska; Laird Bloom; Janet Paulsen; Davinder Gill; Marc Damelin; Orla Cunningham; William J J Finlay
Journal:  J Mol Biol       Date:  2013-02-19       Impact factor: 5.469

8.  Systematic Activity Maturation of a Single-Domain Antibody with Non-canonical Amino Acids through Chemical Mutagenesis.

Authors:  Philip R Lindstedt; Francesco A Aprile; Pietro Sormanni; Robertinah Rakoto; Christopher M Dobson; Gonçalo J L Bernardes; Michele Vendruscolo
Journal:  Cell Chem Biol       Date:  2020-11-19       Impact factor: 8.116

Review 9.  Antibody-drug conjugates in cancer therapy.

Authors:  Eric L Sievers; Peter D Senter
Journal:  Annu Rev Med       Date:  2012-10-03       Impact factor: 13.739

10.  Control of protein phosphorylation with a genetically encoded photocaged amino acid.

Authors:  Edward A Lemke; Daniel Summerer; Bernhard H Geierstanger; Scott M Brittain; Peter G Schultz
Journal:  Nat Chem Biol       Date:  2007-10-28       Impact factor: 15.040

View more
  4 in total

1.  Broadening the Toolkit for Quantitatively Evaluating Noncanonical Amino Acid Incorporation in Yeast.

Authors:  Jessica T Stieglitz; Kelly A Potts; James A Van Deventer
Journal:  ACS Synth Biol       Date:  2021-11-03       Impact factor: 5.110

2.  Engineering Proteins Containing Noncanonical Amino Acids on the Yeast Surface.

Authors:  Rebecca L Hershman; Arlinda Rezhdo; Jessica T Stieglitz; James A Van Deventer
Journal:  Methods Mol Biol       Date:  2022

3.  Yeast Surface Display: New Opportunities for a Time-Tested Protein Engineering System.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Eric T Boder
Journal:  Methods Mol Biol       Date:  2022

4.  Engineered protein-small molecule conjugates empower selective enzyme inhibition.

Authors:  Andrew K Lewis; Abbigael Harthorn; Sadie M Johnson; Roy R Lobb; Benjamin J Hackel
Journal:  Cell Chem Biol       Date:  2021-08-06       Impact factor: 8.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.